Combination of Ranibizumab and Verteporfin Therapy in Neovascular Age-related Macular Degeneration
Clinical trial NCT00967213 · COMPLETED
Trial details
- NCT number
- NCT00967213
- Sponsor
- Novartis Korea Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2008-02-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.